[Skip to Content]
[Skip to Content Landing]
Comment & Response
April 26, 2016

TP53 Gene and Cancer Resistance in Elephants—Reply

Author Affiliations
  • 1University of Utah, Salt Lake City
  • 2Ringling Bros Center for Elephant Conservation, Polk City, Florida
  • 3Arizona State University, Tempe

Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA. 2016;315(16):1790-1791. doi:10.1001/jama.2016.0457

In Reply We agree with Dr Casola that we may have misused the term allele in reference to the additional elephant TP53 (ep53) genes. We also agree, as highlighted in our article, that the exact role of ep53 remains to be determined. Ep53 appears to originate from ancient reverse transcription of TP53 mRNA, followed by a large number of gene duplications. A retrotransposed gene can still encode a protein even if not identical to the ancestral protein, as indicated by our experiments with ep53 retrogene 9. It is unclear if the additional ep53 genes should be called retrogenes or retropseudogenes. Laboratory experiments to answer these questions are ongoing.

First Page Preview View Large
First page PDF preview
First page PDF preview